Loading…
Multi Cap · quant Mutual Fund · AMFI code 100630quant Multi Cap Fund
Disclosed for 93 months, Jan 2019 to Sep 2026.
Portfolio value
₹133 Cr
up ₹33.8 Cr vs Nov 2020
- Stocks held
- 33
- down 7 vs Nov 2020
- Top 10 weight
- 51.9%
- of the portfolio in its ten largest
- Cash & debt
- 3.5%
- cash, money market and debt
- Moves this month
- 9 in · 16 out
- added to 10, trimmed 2
quant Multi Cap Fund is an active equity fund in the Multi Cap category from quant Mutual Fund. In December 2020 it disclosed 33 stocks worth ₹133 Cr, up ₹33.8 Cr from Nov 2020. Its largest positions were Stylam Industries Limited (8.6%), L&T Technology Services Limited (7.4%), Bharti Airtel Limited (7.0%); the ten largest together made up 51.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 23.0% of its equity. Cash and debt stood at 3.5%. Compared with Nov 2020 the fund entered 9 new stocks and exited 16.
Against 32 other Multi Cap funds
Concentration
97%
Top-10 weight is higher than 97% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
38%
Holds more cash than 38% of peers
What these mean: concentration · cash
Holdings in December 2020
Download CSVEvery line the fund disclosed, with the change against Nov 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Stylam Industries Limited | 8.55% | up 0.45 pts | ₹11.4 Cr | up ₹3.3 Cr | Added |
| L&T Technology Services Limited | 7.38% | up 4.20 pts | ₹9.8 Cr | up ₹6.7 Cr | Added |
| Bharti Airtel Limited | 6.98% | up 2.06 pts | ₹9.3 Cr | up ₹4.4 Cr | Added |
| Fortis Healthcare Limited | 6.45% | up 3.88 pts | ₹8.6 Cr | up ₹6 Cr | Added |
| Sun Pharmaceutical Industries Limited | 5.23% | up 2.06 pts | ₹7 Cr | up ₹3.8 Cr | Added |
| Divi's Laboratories Limited | 3.71% | up 3.71 pts | ₹4.9 Cr | up ₹4.9 Cr | New |
| Adani Ports and Special Economic Zone Limited | 3.57% | up 1.29 pts | ₹4.8 Cr | up ₹2.5 Cr | Added |
| Cash, TREPS & receivables | 3.52% | down 8.75 pts | ₹4.7 Cr | down ₹7.5 Cr | Trimmed |
| Alembic Pharmaceuticals Limited | 3.37% | up 2.77 pts | ₹4.5 Cr | up ₹3.9 Cr | Added |
| Hindustan Unilever Limited | 3.35% | up 3.35 pts | ₹4.5 Cr | up ₹4.5 Cr | New |
| Adani Enterprises Limited | 3.30% | down 0.37 pts | ₹4.4 Cr | up ₹74 L | Added |
| Deepak Fertilizers and Petrochemicals Corporation Limited | 3.06% | up 0.79 pts | ₹4.1 Cr | up ₹1.8 Cr | Added |
| Bharat Rasayan Limited Bharat Rasayan Ltd. · history in this fund | 2.97% | down 0.94 pts | ₹4 Cr | up ₹7 L | Added |
| India Financial Services Ltd | 2.95% | down 0.65 pts | ₹3.9 Cr | up ₹35 L | Added |
| ICICI Lombard General Insurance Company Limited | 2.72% | down 0.17 pts | ₹3.6 Cr | up ₹75 L | Added |
| Dabur India Limited | 2.59% | up 2.59 pts | ₹3.4 Cr | up ₹3.4 Cr | New |
| Caplin Point Laboratories Limited | 2.59% | down 0.77 pts | ₹3.4 Cr | up ₹11 L | Added |
| Zydus Lifesciences Limited | 2.58% | up 2.58 pts | ₹3.4 Cr | up ₹3.4 Cr | New |
| Nestle India Limited | 2.52% | up 2.52 pts | ₹3.4 Cr | up ₹3.4 Cr | New |
| Tata Steel Long Products Limited | 2.44% | up 0.69 pts | ₹3.3 Cr | up ₹1.5 Cr | Added |
| Strides Pharma Science Limited | 2.39% | down 0.40 pts | ₹3.2 Cr | up ₹41 L | Added |
| Tata Elxsi Limited | 2.36% | up 2.36 pts | ₹3.1 Cr | up ₹3.1 Cr | New |
| Linde India Limited | 2.30% | down 0.59 pts | ₹3.1 Cr | up ₹19 L | Added |
| Jubilant Pharmova Limited | 2.24% | up 2.24 pts | ₹3 Cr | up ₹3 Cr | New |
| Tata Metaliks Limited | 2.22% | up 2.22 pts | ₹3 Cr | up ₹3 Cr | New |
| Styrenix Performance Materials Limited | 1.42% | up 0.61 pts | ₹1.9 Cr | up ₹1.1 Cr | Added |
| K.P.R. Mill Limited | 1.36% | down 0.67 pts | ₹1.8 Cr | down ₹20 L | Trimmed |
| Uflex Limited | 1.20% | down 0.29 pts | ₹1.6 Cr | up ₹11 L | Added |
| Neuland Laboratories Limited | 1.18% | down 0.31 pts | ₹1.6 Cr | up ₹9 L | Added |
| Matrimony.com Ltd. | 1.02% | down 0.08 pts | ₹1.4 Cr | up ₹27 L | Added |
| India Limited | 0.66% | up 0.66 pts | ₹88 L | up ₹88 L | New |
| Solara Active Pharma Sciences Limited | 0.65% | up 0.18 pts | ₹86 L | up ₹40 L | Added |
| Shilpa Medicare Limited | 0.60% | down 0.24 pts | ₹80 L | down ₹4 L | Trimmed |
| Jash Engineering Limited | 0.56% | down 0.17 pts | ₹75 L | up ₹2 L | Added |
What changed, Nov 2020 to Dec 2020
New New positions (9)
- Divi's Laboratories Limited3.7% · ₹4.9 Cr
- Hindustan Unilever Limited3.4% · ₹4.5 Cr
- Dabur India Limited2.6% · ₹3.4 Cr
- Zydus Lifesciences Limited2.6% · ₹3.4 Cr
- Nestle India Limited2.5% · ₹3.4 Cr
- Tata Elxsi Limited2.4% · ₹3.1 Cr
- Jubilant Pharmova Limited2.2% · ₹3 Cr
- Tata Metaliks Limited2.2% · ₹3 Cr
- India Limited0.7% · ₹88 L
Exited (16)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Nov 2020, the weight rose most in Pharmaceuticals & Biotechnology (+10.3 pts) and IT - Services (+4.0 pts), and fell most in Software (−6.6 pts) and Cement & Cement Products (−3.7 pts).
- Pharmaceuticals & Biotechnology12.6% → 23.0%+10.3 pts
- IT - Services3.6% → 7.6%+4.0 pts
- Healthcare Services2.9% → 6.7%+3.8 pts
- Diversified FMCG0.0% → 3.5%new+3.5 pts
- Ferrous Metals2.0% → 4.8%+2.8 pts
- Personal Products0.0% → 2.7%new+2.7 pts
- Software6.6% → 0.0%exited−6.6 pts
- Cement & Cement Products3.7% → 0.0%exited−3.7 pts
- Electrical Equipment3.2% → 0.0%exited−3.2 pts
- Finance5.9% → 3.1%−2.9 pts
- Industrial Manufacturing3.0% → 0.6%−2.4 pts
- Banks2.2% → 0.0%exited−2.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2019 | Jun 2020 | Sep 2020 | Nov 2020 | Dec 2020 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 4.0% | 25.2% | 14.0% | 12.6% | 23.0% |
| Consumer Durables | — | 0.9% | 9.1% | 9.2% | 8.9% |
| IT - Services | — | 2.4% | — | 3.6% | 7.6% |
| Telecom - Services | — | 7.3% | 6.9% | 5.6% | 7.2% |
| Healthcare Services | 5.6% | — | 2.7% | 2.9% | 6.7% |
| Chemicals & Petrochemicals | — | 13.0% | 6.9% | 7.6% | 5.6% |
| Ferrous Metals | — | — | 0.6% | 2.0% | 4.8% |
| Transport Infrastructure | — | — | 0.7% | 2.6% | 3.7% |
| Diversified FMCG | — | 9.5% | 1.7% | — | 3.5% |
| Metals & Minerals Trading | — | — | 2.3% | 4.2% | 3.4% |
Allocation in Dec 2020change vs Nov 2020
- Pharmaceuticals & Biotechnology (9)23.0%▲ 10.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Dec 2020
3.5%
▼ 8.8 pts vs Nov 2020
- Cash alone
- 3.5%
- cash and net receivables
- A year earlier
- −<0.1%
- Dec 2019 · now ▲ 3.5 pts
- Last 12 months
- −0.1% – 12.3%
- lowest to highest · record 12.3% in Nov 2020
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.